News list for " Nord"

Hilbert Group to Acquire Enigma Nordic for $32 million, Aims to Boost Cryptocurrency Trading Advantage

Swedish investment firm Hilbert Group (HILB), which focuses on algorithmic trading in the cryptocurrency market, acquired high-frequency trading platform Enigma Nordic for $32 million. The company said in a press release that the move allows Hilbert to use Enigma's proprietary trading system, which executes market-neutral strategies on cryptocurrency exchanges worldwide.

clock
2025-12-20 22:53:23
Hilbert Group斥资3200万美元收购Enigma Nordic,旨在提升加密货币交易优势

瑞典投资公司Hilbert Group (HILB) 专注于加密货币市场的算法交易,该公司以3200万美元的价格收购了高频交易平台Enigma Nordic。 该公司在一份新闻稿中表示,此举使希尔伯特能够使用 Enigma 的专有交易系统,该系统可在全球加密货币交易所执行市场中性策略。

clock
2025-12-20 22:53:23
Nordea银行将于12月推出比特币ETP交易服务,响应欧盟MiCA监管框架

Nordea宣布将于2025年12月起向客户提供比特币追踪交易所交易产品(ETP)服务,此举标志着北欧最大银行之一正式进入加密资产领域。该产品由CoinShares International Limited制造,属于合成ETP类别,以比特币为基础资产,专为寻求另类资产敞口的经验丰富投资者设计。 Nordea此前对加密货币持谨慎态度,但随...

clock
2025-10-30 15:44:57
U.S. stocks close: Three major stock indexes fall together, Novo Nordisk falls more than 20%

On July 30, the U.S. stock market closed on Tuesday. The Dow index initially closed down 0.46%, the S & P 500 index fell 0.3%, and the Nasdaq index fell 0.38%. Apple (AAPL. O), Tesla (TSLA. O) and Nvidia (NVDA. O) all fell in the 1% line, while Novo Nordisk (NVO. N) fell 21.8%. The Nasdaq China Golden Dragon index fell 1.35%, Alibaba (BABA. N) fell 2% and Li Auto (LI. O) fell 6%.

clock
2025-07-29 20:01:19
Novo Nordisk (NVO. N) fell 26 percent in premarket trading after the company named a new CEO.

Novo Nordisk (NVO. N) fell 26 percent in premarket trading after the company named a new CEO.

clock
2025-07-29 11:44:24
U.S. pharmaceutical stocks fell premarket, with Novo Nordisk (NVO. N) down 5.25 percent, AbbVie (ABBV. N) down 4.12 percent, AstraZeneca (AZN. O) down 3.8 percent, Novartis (NVS. N) down 3.7 percent, and Gilead Science (GILD. O) down 3.46 percent. Trump predicted...

U.S. pharmaceutical stocks fell premarket, with Novo Nordisk (NVO. N) down 5.25%, AbbVie (ABBV. N) down 4.12%, AstraZeneca (AZN. O) down 3.8%, Novartis (NVS. N) down 3.7% and Gilead Science (GILD. O) down 3.46%. Trump has announced that he will sign an executive order to immediately reduce drug prices by 30% -80%.

clock
2025-05-12 08:10:31
According to Politico, the White House is discussing whether to lift sanctions on Russia's Nord Stream 2 gas pipeline and other Russian assets.

According to Politico, the White House is discussing whether to lift sanctions on Russia's Nord Stream 2 gas pipeline and other Russian assets.

clock
2025-04-24 00:13:22
Russia seeks to restart Nord Stream 2 with US support

On March 2, according to the Financial Times, an ally of Russian President Vladimir Putin has been plotting to restart the Nord Stream 2 gas pipeline to Europe with the support of US investors, a once unthinkable move that shows just how far Trump wants to go with Moscow. The push to broker the deal was the brainchild of Matthias Warnig, a former East German state security official who headed Nord Stream 2's parent company until 2023, according to several people familiar with the discussions. Vo...

clock
2025-03-02 05:11:41
Nordic Bank strategist: US monetary policy has entered a new phase of interest rate cuts depending on falling inflation or a weaker job market

Lars Mouland, credit and rates strategist at Nordic Bank: US monetary policy has entered a new phase in which interest rate cuts depend on falling inflation or a weaker job market. Interest rates could end up higher than market expectations.

clock
2025-01-05 21:27:02
Shocked by the results of Novo Nordisk's weight-loss drug trial, the European Stoxx Healthcare Index fell 4.4%, recording its largest one-day decline since March 2020.

Shocked by the results of Novo Nordisk's weight-loss drug trial, the European Stoxx Healthcare Index fell 4.4%, recording its largest one-day decline since March 2020.

clock
2024-12-20 10:53:14
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.